Albizia lucida
Albizia lucida · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Albizia lucida is a notable botanical species that holds significant interest due to its diverse pharmacological potential. Research focusing on the plant's leaves has revealed that these preparations are rich in bioactive chemical compounds, specifically flavonoids and saponins. These constituents contribute to several vital biological activities, including anticholinesterase and antiplasmodial properties. Furthermore, studies have highlighted the plant's effectiveness in addressing conditions related to the pathogen Staphylococcus aureus. Consequently, the leaf extracts of Albizia lucida represent a promising area for medicinal development.
- Synonyms
- Albizia Lucidior · Inga Lucidior · 3 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Albizia lucida is a botanical species characterized by a complex web of scientific nomenclature. Throughout historical classification, it has been identified by several recognized synonyms, including Acacia lucida and Albizia bracteata. Researchers have also documented its presence under the names Albizia lucidior and Feuilleea lucida. Furthermore, the plant is occasionally referred to in taxonomic literature as Inga lucidior. Understanding these diverse botanical relationships is essential for accurate identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Albizia lucida is a distinct member of the kingdom Plantae. Within this vast biological group, it is specifically classified under the class Equisetopsida. The plant belongs to the order Fabales, which connects it to a diverse array of related species. Further specialization places it within the family Fabaceae, a group known for its significant ecological roles. Finally, it is identified by its specific genus, Albizia, which defines its unique botanical characteristics.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Albizia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Albizia lucida exhibits a broad geographical range that spans across diverse Asian climates. In the temperate regions of East Asia, this species is commonly found throughout China, specifically within the South-Central and Southeast territories. Its presence extends further east to the island of Taiwan, marking a significant part of its temperate distribution. Moving into tropical zones, the plant is well-established across the Indian Subcontinent, including the state of Assam. Additionally, its habitat encompasses parts of Bangladesh, highlighting the plant's adaptability to varying environmental conditions.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Albizia lucida, also referred to in studies as A. lucidior, demonstrates significant pharmacological potential through its diverse secondary metabolites. Research indicates that the plant possesses notable anticholinesterase activity, which is largely driven by a rich concentration of budmunchiamine alkaloids. These specific alkaloids show promise in treating neurological challenges like Alzheimer's disease by inhibiting essential enzymes. Additionally, the species exhibits antiplasmodial activity, offering a possible foundation for the development of new antimalarial treatments. By targeting key proteins such as lactate dehydrogenase in Plasmodium falciparum, the plant's chemical profile highlights its value in modern drug discovery.
Compounds
Conditions
Albizia lucida demonstrates significant medicinal potential through its diverse biological activities. The plant provides antibacterial benefits, as metabolites from endophytic fungi isolated from its leaves can effectively treat Staphylococcus aureus. Furthermore, Albizia lucida exhibits anticholinesterase activity, with its budmunchiamine alkaloids showing promise in treating the acetylcholinesterase enzyme associated with Alzheimer's disease. The species also possesses notable antiplasmodial activity, as its metabolites interact with the lactate dehydrogenase of Plasmodium falciparum. These combined properties highlight the plant's value in addressing bacterial infections, neurological challenges, and malaria.
Preparations
Albizia lucida, identified in the text as Albizia lucidior, is prepared as leaves for various scientific investigations. These leaves are utilized to create ethanolic and ethyl acetate extracts for studying anticholinesterase activity. Researchers also perform untargeted metabolomic analysis on the leaves to identify diverse metabolites like flavonoids and alkaloids. Additionally, the leaves serve as a host for isolating endophytic fungi such as Aspergillus fumigatus. Ultimately, the leaf-derived materials provide critical data for discovering potential treatments for Alzheimer's disease and other infections.
Parts used
Albizia lucida, specifically through its leaves, serves as a rich source of bioactive secondary metabolites with significant medicinal potential. Research into the plant's foliage has revealed a diverse array of budmunchiamine alkaloids that demonstrate promising anticholinesterase activity, offering new avenues for Alzheimer's disease research. Beyond these alkaloids, the leaves also harbor endophytic fungi that produce metabolites capable of inhibiting bacterial growth, such as against Staphylococcus aureus. Comparative metabolomic profiling of the leaves has further identified numerous flavonoids, phenolic acids, and saponins that act as unique chemotaxonomic markers for the species. Ultimately, the chemical complexity found within the leaves of this plant suggests its value in the development of novel treatments for both neurological disorders and infectious diseases.